Scientia Agricultura Sinica ›› 2015, Vol. 48 ›› Issue (16): 3266-3274.doi: 10.3864/j.issn.0578-1752.2015.16.016

• ANIMAL SCIENCE·VETERINARY SCIENCERE·SOURCE INSECT • Previous Articles     Next Articles

Determination of the Activities of Bactrian Camel CYP3A Enzyme by Specific Probe Drug

PEI Le1, ZHANG Wen-bin2, Hasisurong1,3   

  1. 1College of Veterinary Medicine, Inner Mongolia Agricultural University/Key Laboratory of Clinical Diagnosis and Treatment Technology in Animal Disease, Ministry of Agriculture, Hohhot 010018
    2Bactrian Camel Institute of Alashan, Inner Mongolia, Bayanhot 750300, Inner Mongolia
    3Inner Mongolia Institute of Camel Research, Badanjilin 750300, Inner Mongolia
  • Received:2014-10-30 Online:2015-08-16 Published:2015-08-16

Abstract: 【Objective】The objective of this paper is to study the activities of Bactrian camel hepatic CYP3A enzyme in vitro and its influences on exogenous drug metabolism. Method The Bactrian camels were sacrificed by bloodletting in jugular veins after fasting for overnight about 12 hours, and liver tissues were collected immediately from the area of hepatic portal vein, washed away the blood by cold normal saline, and preserved in liquid nitrogen and sent to the lab. The Bactrian camel hepatic microsome was prepared by Ca2+ precipitation method following weighing and homogenate, and then BCA method was used in this experiment for detecting the protein contents of hepatic microsomes. As well as Bactrian camel hepatic microsomal incubation system was optimized, different concentrations of Bactrian camel hepatic microsomal protein suspensions (0.016, 0.031, 0.063, 0.125, 0.250, 0.500, 1.00, 2.000 mg?mL-1), different concentrations of midazolam (MDZ) as probe drug (7.813, 15.625, 31.250, 62.500, 125, 250, 500, 1 000 µg?mL-1) were, respectively, added to the incubation system, after 5 min for preincubation at 37, added the solution of reduced form of nicotinamide-adenine dinucleotide phosphate (NADPH) and incubated again for different times (0, 2, 5, 10, 15, 20, 25, 30 min). The cold methanol and diazepam (DZP) solution were added to the system for terminating the reaction, and vortex mixing, 800 µL mixed liquids were centrifugated at 14 500 r/min for 20 min, 20 µL supernatant was detected by the high performance liquid chromatography with UV method (HPLC-UV) to determine the optimum concentration of substrate, the optimum concentration of enzyme, and the optimal incubation time. Different concentrations of 20 µL MDZ solution (7.813, 15.625, 31.250, 62.500, 125, 250, 500, 1 000 µg?mL-1) as probe drug were incubated with Bactrian camel hepatic microsomes for 15 min, respectively, and then the reaction was terminated by ice-cold methanol mixed with the internal standard of diazepam. The dynamic contents of reaction metabolite 1′-Hydroxymidazolam (1′-OHMDZ) were detected by the HPLC-UV method, and some pharmacokinetic parameters were calculated. Chromatographic conditions were Sigma-Aldrich/Supelco Discovery C18 chromatographic column (150 mm×4.6 mm, 5 µm), mobile phase of V (acetonitrile) was V (0.01 mol?L-1 PBS) = 40:60, the elution lasted for 20 min with the same concentration, the detection wavelength was 254 nm, a flow rate was 0.8 mL?min-1, column temperature was 30, and the  injection volume was 20 μL. Result Bactrian camel hepatic microsomes, which were prepared by the Ca2+ precipitation method, maintained a good activity to meet the basic requirements of the following-up drug metabolism tests in vitro, and the protein content of hepatic microsomes was (1.936±0.052) mg?mL-1. The Bactrian camel hepatic microsomal incubation system was constituted by bactrian camel hepatic microsomal protein suspensions, midazolam as probe drug, PBS buffer, MgCl2 solution and NADPH solution. With the extension of the incubation time, the enzyme and substrates were further reacted, when the concentration of MDZ was 125 μg?mL-1 (final concentration was 7.073 nmol?mL-1), and the concentration of hepatic microsomes was 2.000 mg?mL-1 (final concentration was 0.050 mg?mL-1), and the incubation time was 15 min, the enzyme and substrate most closely reacted to the saturated state, and the final concentration and the incubation time were determined to the optimum ones. The retention times of 1′-OHMDZ, MDZ and DZP were 6.710 min, 11.383 min, and 15.263 min, respectively, by detection of HPLC-UV method, and the chromatographic peak of each component was completely separated, which was not influenced by the other interfering peaks in the Bactrian camel hepatic microsomal incubation system. The precision, stability and recovery test results of HPLC detection method were consistent with the basic requirements of chromatography, and an accurate, sensitive, reliable, and reproducible detection method was successfully established for Bactrian CYP3A enzyme specific probe drugs. The concentration of substrate MDZ and the generation rate of metabolite 1′- OHMDZ were used to draw a double-reciprocal plot (Lineweaver-Burk plot), and maximum reaction rate Vmax and Michaelis constant Km were calculated by Origin Pro8.6 software for the analysis of linear regression. The Vmax and Km were (0.380±0.028) nmol?mg-1?min-1 and (9.603±3.229) nmol?mL-1, respectively, which showed the reaction of enzyme and substrates, and determined the activities of Bactrian camel CYP3A enzyme indirectly. ConclusionThe HPLC-UV method for detecting the concentration of midazolam, which is the specific probe drug of CYP3A enzyme, and its metabolites were established successfully. The essential metabolite of MDZ oxidized by specific CYP3A enzymes in the body was 1′- OHMDZ. The metabolic activities of Bactrian camel CYP3A enzyme in vitro, and the characteristics of enzyme-substrate interaction were preliminarily studied for the first time using the generation rate of essential metabolite as a detection indicator.

Key words: Bactrian camel, CYP3A enzyme, HPLC-UV, probe drugs, Bactrian camel, CYP3A enzyme, HPLC-UV, probe drugs

[1]    Nelson D R, Koymans L, Kamataki T, Stegeman J J, Feyereisen R, Waxman D J, Waterman M R, Gotoh O, Coon M J, Estabrook R W, Gunsalus I C, Nebert D W. P450 super family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 1996, 6(1): 1-42.
[2]    李拴美. CYP450 3A及其等位基因在体外药物代谢和药物相互作用中的对比研究[D]. 西安: 西北大学, 2009.
Li S M. Comparative study of drug metabolisms and drug-drug interactions of human cytochrome P450 3A and its alleles in vitro[D]. Xi ‘an: Northwestern University, 2009. (in Chinese)
[3]    Wrighton S A, Schuetz E G, Thummel K E, Shen D D, Korzekwa K R, Warkins P B. The human CYP3A subfamily: practical considerations. Drug Metabolism Reviews, 2000, 32 (3/4): 339-361.
[4]    Jirimutu, Wang Z, Ding G H, Chen G L, Sun Y M, Sun Z H, Zhang H P, Wang L, Hasi S R, Zhang Y, Li J M, Shi Y X, Xu Z, He C, Yu S, Li S, Zhang W B, Batmunkh M, Ts B, Narenbatu, Unierhu, Bat-Ireedui S, Gao H W, Baysgalan B, Li Q, Jia Z L, Turigenbayila, Subudenggerile, Narenmanduhu, Wang Z X, Wang J, Pan L, Chen Y C, Ganerdene Y, Dabxilt, Erdemt, Altansha, Altansukh, Liu T, Cao M H, Aruuntsever, Bayart, Hosblig, He F, Zhati A, Zheng G Y, Qiu F, Sun Z, Zhao L L, Zhao W J, Liu B H, Li C, Chen Y Q, Tang X Y, Guo C Y, Liu W, Ming L, Temuulen, Cui1 A, Li Y, Gao J H, Li J, Wurentaodi, Niu S, Sun T, Zhai Z X, Zhang M, Chen C, Baldan T, Bayaer T, Li Y X, Meng H. Genome sequences of wild and domestic Bactrian camels. Nature Communications, 2012, 3:1202.
[5]    李筱旻. 内源性氢化可的松代谢评价体内CYP3A活性研究[D]. 长沙: 中南大学, 2007.
Li X M. Study on the CYP3A phenotyping in human by endogenous cortisol metabolism[D]. Changsha: Central South University, 2007. (in Chinese)
[6]    Nordt S P, Clark R F. Midazolam: a review of therapeutic uses and toxicity. The Journal of Emergency Medicine, 1997, 15: 357-365.
[7]    Kanazawa H, Okada A, Igarashi E, Higaki M, Miyabe T, Sano T, Nishimura R. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography- mass spectrometry. Journal of Chromatography A, 2004, 1031: 213-218.
[8]    Lepper E R, Hicks J K, Verweij J, Zhai S, Figg W D, Sparreboom A. Determination of midazolam in human plasma by liquid chromatography with mass- spectrometric detection. Journal of Chromatography B, 2004, 806: 305-310.
[9]    Toyo’oka T, Kumaki Y, Kanbori M, Kato M, Nakahara Y. Determination of hypnotic benzodiazepines (alprozolam, estazolam, and midazolam) and their metabolites in rat hair and plasma by reversed-phase liquid-chromatography with electrospray ionization mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 2003, 30: 1773-1787.
[10]   胡屹屹. 猪肝微粒体细胞色素P450酶系的初步研究[D]. 南京: 南京农业大学, 2006.
Hu Q Q. Preliminary study on micromal cytochrome P450 enzymes in pigs[D]. Nanjing: Nanjing Agricultural University, 2006. (in Chinese)
[11]   张慧锋, 王月鹏, 李妍. 细胞色素P450的研究进展.吉林医药学院学报, 2005, 26(3): 174-177.
Zhang H F, Wang Y P, Li Y. Research development of cytochrome P450. Journal of Jilin Medical College, 2005, 26(3): 174-177. (in Chinese)
[12]   Badyal D K, Dadhich A P. Cytochrome P450 and drug interactions. Indian Journal of Pharmacology, 2001, 33: 248-259.
[13]   Thörn M, Lundgren S, Herlenius G, Ericzon B, Loof L, Rane A. Gene expression of cytochromes P450 in liver transplants over time. European Journal of Clinical Pharmacology, 2004, (60): 413-420.
[14]   邱星辉, 冷欣夫. 细胞色素P450的多样性. 生命的化学, 1997, 17(6): 13-16.
Qiu X H, Leng X F. Diversity of cytochrome P450. Chemistry of Life, 1997, 17(6): 13-16. (in Chinese)
[15]   李超. 五种6, 7-呋喃香豆素对大鼠肝微粒体细胞色素P4501A2和2E1活性的影响[D]. 山东: 泰山医学院, 2009.
Li C. Effects of five 6,7-furocoumarins on the hepatic microsome cytochrome P450 1A2, 2E1 a activity in rats[D]. Shandong: Taishan Medical University, 2009. (in Chinese)
[16]   刘兆颖. 喹噁啉类在大鼠、猪和鸡的比较代谢研究[D]. 武汉: 华中农业大学, 2009.
Liu Z Y. Comparative metabolism of quinoxalines in rats, swine and chicken[D]. Wuhan: Huazhong Agricultural University, 2009. (in Chinese)
[17]   简暾昱, 徐帆, 廖春龙, 徐贵丽. 3种方法测定大鼠肝微粒体蛋白含量的比较. 中国药师, 2011, 14(3): 342-345.
Jian T Y, Xu F, Liao C L, Xu G L. Comparison of three methods for determining rat liver microsomal protein content. China Pharmacist, 2011, 14(3): 342-345. (in Chinese)
[18]   裴乐, 张文彬, 巴拉, 哈斯苏荣. 双峰驼CYP3A酶体外活性检测方法的建立. 2013中国驼业进展, 2013:101-108.
Pei L, Zhang W B, Ba L, Hasi S R. Preliminary establishment of detection method for bactrian camel liver microsomal CYP3A enzyme activity. 2013 China Camel Industry Development, 2013: 101-108.(in Chinese)
[19]   裘福荣, 张荣, 孙建国, 王广基, 蒋健, 马越鸣. HPLC法测定人肝微粒体6β-羟基睾酮和1-羟基咪达唑仑浓度. 中国临床药学杂志, 2010, 19(03): 145-148.
Qiu F R, Zhang R, Sun J G, Wang G J, Jiang J, Ma Y M. Determination of 6β-hydroxytestosterone and 1-hydroxymidazolam in human liver microsomes by HPLC. Chinese Journal of Clinical Pharmacy, 2010, 19(03): 145-148. (in Chinese)
[20]   苏明威, 辛华雯, 李维亮, 熊磊, 余爱荣, 李罄, 王乃平. HPLC法测定CYP 3A4酶活性的研究. 华南国防医学杂志, 2009, 23(5): 53-56.
Su M W, Xin H W, Li W L, Xiong L, Yu A R, Li Q, Wang N P. Determination of Cytochrome P450 3A4 activity using high performance liquid chromatography. Military Medical Journal of South China, 2009, 23(5): 53-56. (in Chinese)
[21]   任秀华, 曹磊, 斯陆勤, 薛柯雯, 裘军, 李高. 大鼠肝细胞色素P4503A活性测定及其孵育条件的优化. 中国医院药学杂志, 2010, 30(10): 809-812.
Ren X H, Cao L, Si L Q, Xue K W, Qiu J, Li G. Determination of the activity of cytochrome P450 3A in rat liver microsomes by HPLC and optimization of the incubated conditions in vitro. Chinese Journal of Hospital Pharmacy, 2010, 30(10): 809-812. (in Chinese)
[22]   刘洁. “Cocktail”探针药物法评价丹参酮ⅡA对大鼠肝微粒体细胞色素P450不同亚型体外代谢活性的影响[D]. 天津: 天津医科大学, 2012.
Liu J. Influence of Tanshinone IIA on cytochrome P450 isoforms by Cocktail approach in rat liver microsomes in vitro[D]. Tianjin: Tianjin Medical University, 2012. (in Chinese)
[23]   夏宗玲, 陈荣, 王明丽. 雌性大鼠细胞色素P4503A酶诱导模型建立与验证. 中国药学杂志, 2013, 48(12): 995-999.
Xia Z L, Chen R, Wang M L. Establishment and verification of cytochrome P450 3A enzyme induction model in female rats. Chinese Pharmaceutical Journal, 2013, 48(12): 995-999. (in Chinese)
[24]   Cinti D L, Moldeus P, Schenkman J B. Kinetic parameters of drug-metabolizing enzymes in Ca2+-sedimented microsomes from rat liver. Biochemical Pharmacology, 1972, 21(24): 3249-3256.
[25]   王莉娥, 杨明学, 谢广云. 一种用聚乙二醇制备微粒体的方法.生物化学与生物物理进展, 1995, 22(5): 462-464.
Wang L E, Yang M X, Xie G Y. A preparation of microsomes with polyethylene glycol. Progress In Biochemistry and Biophysics, 1995, 22(5): 462-464. (in Chinese)
[26]   Yang J, Wang Y J, Pan L, Li N, Lu X M, Guan J, Cheng M S, Li F M. Enantioselective determination of trantinterol in rat plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry after derivatization. Talanta, 2009, 79(5): 1204-1208.
[27]   Yoshihara S, Mizutare T, Makishima M, Suzuki N, Fujimoto N, Igarashi K, Ohta S. Potent estrogenic metabolites of Bisphenol A and Bisphenol B formed by rat Liver S9 fraction: their structures and estrogenic potency. Toxicological Sciences, 2004, 78(1): 50-59.
[28]   翁小刚. 戊己丸提取物不同配伍组方对大鼠CYP450酶的影响研究[D]. 北京: 中国中医科学院, 2010.
Weng X G. Effects of Wuji Pill compound with different compatibility on Cytochrome P450 of Rat[D]. Beijing: China Acadmy of Chinese Medical Sciences, 2010. (in Chinese)
[29]   Thorir D. B, John T. C, Heidi J. E, Volker F, Lawrence G, Scott G, John K, S. Peter K, Gerald M, Lan N, Gondi K, James M, R. Scott O, Stanley R, Amy R, Anita S, Fred S, John T. S, Donald T, Jose M. V, Stanley R, Amy R, Anita S, Fred S, John T. S, Donald T, Jose M. V, John W, Steven A. W: The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metabolism and Disposition, 2003, 31(7): 815-832.
[30]   Schnell S, Maini P K. A century of enzyme kinetics: reliability of the Km and Vmax estimates. Comments on Theoretical Biology, 2003, 8(2/3): 169-187.
[31]   郭炜. 盐酸双苯氟嗪在大鼠肝微粒体内的代谢特征研究[D]. 石家庄: 河北医科大学, 2011.
Guo W. The metabolism characteristics of dipfluzine hydrochloride in rat liver microsomes[D]. Shijiazhuang: Hebei Medical University, 2011. (in Chinese)
[32]   翁燕. 细胞色素P450酶的抑制、时间依赖性抑制和诱导模型[D]. 上海: 复旦大学, 2012.
Weng Y. In vitro assessment of CYP Inhibition, time-dependent inhibition in human liver microsomes and CYP Induction in human hepatocyte[D]. Shanghai: Fudan University, 2012. (in Chinese)
[33]   Gushchin G V, Gushchin M I, Gerber N, Boyd R T. A novel cytochrome P450 3A isoenzyme in rat intestinal microsomes. Biochemical and Biophysical Research Communications, 1999, 255: 394-398.
[34]   Williams J A, Hyland R, Jones B C, Smith D A, Hurst S, Goosen T C, Peterkin V, Koup J R, Ball S E. Drug-drug interactions for UDP- glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metabolism and Disposition, 2004, 32(11): 1201-1208.
[35]   邱相君, 王哲, 徐涛, 罗顺斌, 胡国新. 高效液相色谱法测定大鼠肝微粒体CYP3A酶的活性. 中国临床药理学杂志, 2012, 28(11): 852-856.
Qiu X J, Wang Z, Xu T, Luo S B, Hu G X. Determination of the activity of CYP3A in rat liver microsomes by HPLC. The Chinese Journal of Clinical Pharmacology, 2012, 28(11): 852-856. (in Chinese)
[1] LiKang ZHI, Erdemtu, XiWen AN, Chao WANG, Rui WANG, Huar BAO, XiuZhen WANG. Mapping and Annotating of Bactrian Camel MHC Gene by Using the Comparative Genomic Approach [J]. Scientia Agricultura Sinica, 2018, 51(18): 3591-3599.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!